Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach
Initiative follows Archenia acquisition and Marchex’s evolution into a comprehensive AI-driven customer acquisition and outcome optimization platform
Superstar Platforms Announces Agreement to Acquire TitlePal, Inc.
Acquisition expands Superstar’s fintech portfolio with a digital-first platform designed to modernize the traditionally storefront-based vehicle title lending industry
Travel Trackers Acquired by Volaris Group
Travel Trackers is a tuck-in to Adapt IT Hospitality’s ResRequest business in South Africa, further strengthening its hospitality expertise
FactSet Marks a New Era in Enterprise Real-Time Market Data as It Acquires BCC Group International
NORWALK, Conn., Sept. 22, 2026 (GLOBE NEWSWIRE) — FactSet, a leading global intelligence and AI solutions provider to the financial markets, today announced the acquisition of BCC Group International GmbH (bccg), a financial software development firm specializing in cloud-native and hybrid market data distribution platforms. The acquisition marks a milestone in the expansion of FactSet’s Real-Time Solution Suite, strengthening its market data management capabilities. Combined with its premium Real-Time Consolidated Data Feeds, it helps firms meet the demands of a rapidly evolving capital markets landscape.
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
Beam Global Enters LOI to Acquire European Drone Technology Company and Position Beam to Become a Vertically Integrated Drone Company
Nedap launches Nedap Way: secure building access with its next-generation reader line
21shares Expands Product Suite with Launches of ether.fi ETP (ETHFI) and Zcash ETP (ZCASH)
New physically backed products broaden European investor access to decentralised financial platforms,privacy-focused digital assets and quantum-resistant architecture via standard brokerage accounts
AI Data Center Interconnect Market Expands as Distributed AI Workloads Drive Demand for High-Speed Optical Connectivity
Sampo has reduced its ownership in NOBA
Sampo plc, press release, 22 September 2026 at 9:20 am EEST
Sampo on vähentänyt omistustaan NOBAssa
Sampo Oyj, lehdistötiedote, 22.9.2026 klo 9.20
TradersYard Shifts Focus to Futures Trading
VIENNA, Sept. 22, 2026 (GLOBE NEWSWIRE) — TradersYard today announced that it is making futures trading challenges its primary strategic focus, following strong growth in its futures business over recent months and the funding round announced in July 2026.
Lake Energy Launches Renewable Energy RWAs Through Blockchain-Based Platform
SINGAPORE, Sept. 22, 2026 (GLOBE NEWSWIRE) — Lake Energy has announced the launch of a platform for the tokenization of renewable energy Real World Assets (RWAs), enabling renewable energy infrastructure assets to be represented and managed on a blockchain-based platform.
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity
Basel, 22 September 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) today announced positive topline results from CT-388-104, a Phase II clinical trial evaluating enicepatide (CT-388), an investigational, once-weekly dual GLP-1/GIP receptor agonist, in adults living with type 2 diabetes (T2D) and overweight or obesity. In the study, enicepatide met both primary endpoints, delivering dose-dependent and clinically meaningful reductions in blood glucose and body weight at 48 weeks. Patients receiving the highest titrated dose (24 mg) achieved an HbA1c reduction of 2.65% (from a baseline HbA1c of 8.1%). Furthermore, 90% of patients in the 24 mg cohort reached an HbA1c level of ≤6.5% (diagnostic threshold for T2D) and 62% achieved normoglycemia (HbA1c < 5.7%), restoring blood glucose levels to a non-diabetic range. The mean weight loss at 48 weeks in the 24 mg enicepatide arm was 15.5% without a demonstrable plateau.
match.asia Builds AI-Native Investment Bank for Southeast Asian SMEs
AI-native M&A model combines experienced deal professionals and technology to provide selected SMEs with success-fee-only transaction facilitation, broader buyer access and stronger execution support